Wells Fargo downgraded Ashland from Overweight to Equal Weight
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/15/2025 | $71.00 | Market Perform → Outperform | BMO Capital Markets |
| 9/8/2025 | $60.00 | Equal-Weight | Morgan Stanley |
| 5/1/2025 | Overweight → Equal Weight | Wells Fargo | |
| 3/26/2025 | $68.00 → $71.00 | Neutral → Overweight | Analyst |
| 3/5/2025 | Buy → Neutral | Seaport Research Partners | |
| 8/8/2024 | $90.00 → $89.00 | Underweight → Neutral | JP Morgan |
| 4/11/2024 | $100.00 → $112.00 | Equal Weight → Overweight | Wells Fargo |
| 3/14/2024 | $100.00 → $126.00 | Hold → Buy | Jefferies |
Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall sales by approximately $10 million or two percent versus the prior-year quarter; excluding the Avoca divestiture, sales declined three percentLoss from continuing operations of $14 million, or $(0.30) per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $12 million, or $0.26 per diluted shareNet loss of $12 million, or $(0.26) per diluted shareAdjusted EBITDA of $58 million, down five percent from the prior-year quarter, with the Avoca divestiture contributing to a two percent or $1 million decline; excluding the Avoca
Expanding access in EMEA markets to meet rising demand for functional ingredients and drive innovation in food and beverage applications ESSEN, Germany, Jan. 27, 2026 /PRNewswire/ -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC ("Univar Solutions" or "The Company"), a leading global solutions provider of specialty ingredients and chemicals, today announced an exclusive distribution partnership between their Foodology by Univar Solutions business and Ashland Inc. (NYSE:ASH). Ashland is a global, consumer-focused additives and specialty ingredients company recognized for its leading cellulose ether derivatives and polyvinylpolypyrrolidone (PVPP). Beginning January 1, 2026, this
WILMINGTON, Del., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its first-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Monday, February 2, 2026. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Tuesday, February 3. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief fina
BMO Capital Markets upgraded Ashland from Market Perform to Outperform and set a new price target of $71.00
Morgan Stanley initiated coverage of Ashland with a rating of Equal-Weight and set a new price target of $60.00
Wells Fargo downgraded Ashland from Overweight to Equal Weight
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
8-K - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan
Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu
Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio
Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall sales by approximately $10 million or two percent versus the prior-year quarter; excluding the Avoca divestiture, sales declined three percentLoss from continuing operations of $14 million, or $(0.30) per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $12 million, or $0.26 per diluted shareNet loss of $12 million, or $(0.26) per diluted shareAdjusted EBITDA of $58 million, down five percent from the prior-year quarter, with the Avoca divestiture contributing to a two percent or $1 million decline; excluding the Avoca
WILMINGTON, Del., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its first-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Monday, February 2, 2026. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Tuesday, February 3. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief fina
WILMINGTON, Del., Jan. 19, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on March 15, 2026, to stockholders of record at the close of business on March 1, 2026. As of December 31, 2025, there were 45,762,391 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coat
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND INC. (0001674862) (Subject)